These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11286396

  • 1. Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells.
    Ozaki K, Yamamoto T, Ishibashi T, Matsubara T, Nishio M, Aizawa Y.
    Jpn J Pharmacol; 2001 Feb; 85(2):147-54. PubMed ID: 11286396
    [Abstract] [Full Text] [Related]

  • 2. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D, Hayashi T, Thakur NK, Jayachandran M, Asai Y, Kano H, Matsui H, Iguchi A.
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
    Xenos ES, Stevens SL, Freeman MB, Cassada DC, Goldman MH.
    Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
    [Abstract] [Full Text] [Related]

  • 4. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules.
    Mueck AO, Seeger H, Wallwiener D.
    Exp Clin Endocrinol Diabetes; 2001 May; 109(3):181-3. PubMed ID: 11409302
    [Abstract] [Full Text] [Related]

  • 5. Fluvastatin reduces endothelin secretion of cultured human umbilical vein endothelial cells.
    Mueck AO, Seeger H, Lippert TH.
    Eur J Clin Pharmacol; 1999 Nov; 55(9):625-6. PubMed ID: 10638389
    [Abstract] [Full Text] [Related]

  • 6. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
    Mitani H, Egashira K, Ohashi N, Yoshikawa M, Niwa S, Nonomura K, Nakashima A, Kimura M.
    Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
    [Abstract] [Full Text] [Related]

  • 7. Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide.
    Skogastierna C, Luksha L, Kublickiene K, Eliasson E, Rane A, Ekström L.
    Heart Vessels; 2011 Nov; 26(6):628-36. PubMed ID: 21213109
    [Abstract] [Full Text] [Related]

  • 8. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
    Aoki C, Nakano A, Tanaka S, Yanagi K, Ohta S, Jojima T, Kasai K, Takekawa H, Hirata K, Hattori Y.
    Int J Cardiol; 2012 Apr 05; 156(1):55-61. PubMed ID: 21093076
    [Abstract] [Full Text] [Related]

  • 9. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism.
    Abe K, Nakayama M, Yoshimura M, Nakamura S, Ito T, Yamamuro M, Sakamoto T, Miyamoto Y, Yoshimasa Y, Saito Y, Nakao K, Yasue H, Ogawa H.
    Pharmacogenet Genomics; 2005 May 05; 15(5):329-36. PubMed ID: 15864134
    [Abstract] [Full Text] [Related]

  • 10. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells.
    Hattori Y, Nakanishi N, Akimoto K, Yoshida M, Kasai K.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):176-82. PubMed ID: 12588756
    [Abstract] [Full Text] [Related]

  • 11. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.
    Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G, Molteni R, Khamashta MA, Tremoli E, Camera M.
    Arthritis Rheum; 2001 Dec 01; 44(12):2870-8. PubMed ID: 11762948
    [Abstract] [Full Text] [Related]

  • 12. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
    Nishimatsu H, Suzuki E, Satonaka H, Takeda R, Omata M, Fujita T, Nagai R, Kitamura T, Hirata Y.
    Am J Physiol Heart Circ Physiol; 2005 Apr 01; 288(4):H1770-6. PubMed ID: 15550522
    [Abstract] [Full Text] [Related]

  • 13. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S.
    J Clin Invest; 1998 Jun 15; 101(12):2711-9. PubMed ID: 9637705
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L, Banfi C, Sironi L, Arpaia M, Tremoli E.
    Thromb Haemost; 2000 Jul 15; 84(1):59-64. PubMed ID: 10928471
    [Abstract] [Full Text] [Related]

  • 15. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.
    Murata T, Kinoshita K, Hori M, Kuwahara M, Tsubone H, Karaki H, Ozaki H.
    Arterioscler Thromb Vasc Biol; 2005 Nov 15; 25(11):2335-42. PubMed ID: 16166567
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells.
    Sekiya A, Morishita E, Maruyama K, Torishima H, Ohtake S.
    J Atheroscler Thromb; 2015 Jul 23; 22(7):660-8. PubMed ID: 25735397
    [Abstract] [Full Text] [Related]

  • 17. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C, Ortiz JA, Ramos MM, Haro D, Hegardt FG.
    Arch Biochem Biophys; 2000 Feb 15; 374(2):286-92. PubMed ID: 10666309
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N, Hayashi Y, Takahashi Y, Hattori Y.
    J Pharmacol Exp Ther; 2006 Dec 15; 319(3):1348-54. PubMed ID: 17003232
    [Abstract] [Full Text] [Related]

  • 19. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells.
    Potena L, Frascaroli G, Grigioni F, Lazzarotto T, Magnani G, Tomasi L, Coccolo F, Gabrielli L, Magelli C, Landini MP, Branzi A.
    Circulation; 2004 Feb 03; 109(4):532-6. PubMed ID: 14744969
    [Abstract] [Full Text] [Related]

  • 20. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart.
    Obata T, Ebihara A, Yamanaka Y.
    Biochim Biophys Acta; 2001 Apr 30; 1536(1):55-63. PubMed ID: 11335104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.